The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase II trial of carboplatin, pemetrexed, and bevacizumab in metastatic nonsquamous (NSC) lung cancer.
Michael J. Guarino
Research Funding - Lilly
Gregory A. Masters
No relevant relationships to disclose
David Biggs
No relevant relationships to disclose
Charles Schneider
No relevant relationships to disclose
Jamal Ghazi Misleh
No relevant relationships to disclose
Pamela S. Simpson
No relevant relationships to disclose
Kathiresan Suppiah
No relevant relationships to disclose
Timothy F. Wozniak
No relevant relationships to disclose
Stephen S. Grubbs
No relevant relationships to disclose